European Growth Companies With High Insider Ownership Expecting Up To 97% Earnings Growth
Reviewed by Simply Wall St
As the European markets experience a modest uplift, buoyed by expectations of lower U.S. borrowing costs and a rebound in manufacturing activity, investors are increasingly turning their attention to growth companies with high insider ownership. In such an environment, stocks that combine robust earnings potential with significant insider investment can offer compelling opportunities for those seeking to align with company leadership's confidence in future performance.
Top 10 Growth Companies With High Insider Ownership In Europe
Name | Insider Ownership | Earnings Growth |
Xbrane Biopharma (OM:XBRANE) | 21.8% | 64.3% |
Pharma Mar (BME:PHM) | 11.8% | 44.2% |
MedinCell (ENXTPA:MEDCL) | 13.9% | 91% |
Marinomed Biotech (WBAG:MARI) | 29.7% | 20.2% |
KebNi (OM:KEBNI B) | 38.4% | 63.7% |
Elliptic Laboratories (OB:ELABS) | 24.4% | 80.6% |
Circus (XTRA:CA1) | 24.7% | 72.6% |
CD Projekt (WSE:CDR) | 29.7% | 39.5% |
Bonesupport Holding (OM:BONEX) | 10.4% | 59.7% |
Bergen Carbon Solutions (OB:BCS) | 12% | 64.6% |
We're going to check out a few of the best picks from our screener tool.
Moreld (OB:MORLD)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Moreld AS offers integrated solutions for the energy, marine, and industrial sectors both in Norway and internationally, with a market cap of NOK3.13 billion.
Operations: The company's revenue segments include Moreld Apply with NOK4.45 billion and Global Maritime with NOK874.53 million.
Insider Ownership: 31.5%
Earnings Growth Forecast: 67.9% p.a.
Moreld is trading significantly below its estimated fair value, suggesting potential undervaluation. Despite a forecasted revenue decline of 3.7% annually over the next three years, Moreld's earnings are expected to grow by 67.92% per year, transitioning to profitability, which is above average market growth. Recent financial results show strong revenue growth and a shift from net loss to profit. The company has announced a quarterly dividend policy with a recent distribution of NOK 0.42 per share for Q3 2025.
- Take a closer look at Moreld's potential here in our earnings growth report.
- Our comprehensive valuation report raises the possibility that Moreld is priced lower than what may be justified by its financials.
Formycon (XTRA:FYB)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Formycon AG is a biotechnology company focused on developing biosimilar drugs in Germany and Switzerland, with a market cap of €425.71 million.
Operations: The company generates revenue primarily from its biotechnology segment, amounting to €51.78 million.
Insider Ownership: 14.2%
Earnings Growth Forecast: 97.7% p.a.
Formycon is poised for substantial growth, with revenue expected to increase by 27.3% annually, outpacing the German market. Despite current financial challenges, including a net loss of €54.19 million for the first half of 2025 and reduced sales, Formycon remains committed to achieving its full-year revenue target of €55-65 million. The company has streamlined its clinical development program for FYB206 and secured strategic distribution agreements in Europe and Latin America, enhancing its biosimilar portfolio's reach.
- Dive into the specifics of Formycon here with our thorough growth forecast report.
- The valuation report we've compiled suggests that Formycon's current price could be inflated.
init innovation in traffic systems (XTRA:IXX)
Simply Wall St Growth Rating: ★★★★★☆
Overview: init innovation in traffic systems SE, along with its subsidiaries, provides intelligent transportation systems solutions for public transportation globally and has a market cap of €437.96 million.
Operations: The company's revenue segment primarily consists of Wireless Communications Equipment, generating €292.95 million.
Insider Ownership: 40%
Earnings Growth Forecast: 31.2% p.a.
init innovation in traffic systems SE is experiencing robust revenue growth, projected at 11.7% annually, surpassing the German market average. Despite a slight decline in net profit margins from last year, earnings are expected to grow significantly over the next three years. Recent developments include a raised revenue forecast for 2025 due to additional funding for the AFC 2.0 project, although this expansion will have limited impact on earnings. The company trades near its fair value estimate with no substantial insider trading activity reported recently.
- Delve into the full analysis future growth report here for a deeper understanding of init innovation in traffic systems.
- The analysis detailed in our init innovation in traffic systems valuation report hints at an inflated share price compared to its estimated value.
Make It Happen
- Unlock more gems! Our Fast Growing European Companies With High Insider Ownership screener has unearthed 213 more companies for you to explore.Click here to unveil our expertly curated list of 216 Fast Growing European Companies With High Insider Ownership.
- Curious About Other Options? The end of cancer? These 26 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if init innovation in traffic systems might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About XTRA:IXX
init innovation in traffic systems
Engages in the provision of intelligent transportation systems solutions for public transportation worldwide.
High growth potential with excellent balance sheet.
Similar Companies
Market Insights
Community Narratives


